Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 51905 | 12.7091 |
09:34 ET | 8958 | 12.53 |
09:36 ET | 3244 | 12.47 |
09:38 ET | 1887 | 12.52 |
09:39 ET | 2742 | 12.55 |
09:41 ET | 3886 | 12.6 |
09:43 ET | 4565 | 12.49 |
09:45 ET | 28798 | 12.41 |
09:48 ET | 5345 | 12.47 |
09:50 ET | 7530 | 12.43 |
09:52 ET | 6116 | 12.4347 |
09:54 ET | 800 | 12.46 |
09:56 ET | 4771 | 12.47 |
09:57 ET | 6754 | 12.435 |
09:59 ET | 1246 | 12.39 |
10:01 ET | 5091 | 12.37 |
10:03 ET | 400 | 12.375 |
10:06 ET | 5005 | 12.44 |
10:08 ET | 1100 | 12.58 |
10:10 ET | 5118 | 12.49 |
10:12 ET | 1617 | 12.44 |
10:14 ET | 1500 | 12.38 |
10:15 ET | 1703 | 12.36 |
10:17 ET | 4277 | 12.29 |
10:19 ET | 1301 | 12.3 |
10:21 ET | 4339 | 12.21 |
10:24 ET | 8836 | 12.18 |
10:26 ET | 13518 | 12.2374 |
10:28 ET | 7770 | 12.24 |
10:30 ET | 1575 | 12.26 |
10:32 ET | 1332 | 12.2 |
10:33 ET | 6177 | 12.22 |
10:35 ET | 1200 | 12.28 |
10:37 ET | 870 | 12.305 |
10:42 ET | 400 | 12.35 |
10:44 ET | 1000 | 12.33 |
10:46 ET | 600 | 12.38 |
10:48 ET | 300 | 12.38 |
10:50 ET | 1206 | 12.31 |
10:51 ET | 1618 | 12.285 |
10:53 ET | 1691 | 12.32 |
10:55 ET | 400 | 12.3 |
10:57 ET | 302 | 12.3156 |
11:00 ET | 861 | 12.28 |
11:02 ET | 2200 | 12.29 |
11:04 ET | 6254 | 12.335 |
11:06 ET | 652 | 12.33 |
11:08 ET | 1707 | 12.32 |
11:09 ET | 100 | 12.3 |
11:13 ET | 1821 | 12.26 |
11:15 ET | 200 | 12.28 |
11:18 ET | 2995 | 12.3 |
11:20 ET | 879 | 12.29 |
11:22 ET | 1000 | 12.26 |
11:24 ET | 734 | 12.245 |
11:26 ET | 1251 | 12.24 |
11:27 ET | 700 | 12.25 |
11:29 ET | 100 | 12.25 |
11:31 ET | 2283 | 12.28 |
11:33 ET | 326 | 12.26 |
11:36 ET | 100 | 12.28 |
11:38 ET | 100 | 12.2672 |
11:40 ET | 1555 | 12.28 |
11:44 ET | 563 | 12.27 |
11:45 ET | 105112 | 12.2375 |
11:47 ET | 1729 | 12.24 |
11:49 ET | 1610 | 12.23 |
11:51 ET | 62364 | 12.145 |
11:54 ET | 19295 | 12.09 |
11:56 ET | 8044 | 12.1081 |
11:58 ET | 13809 | 12.15 |
12:00 ET | 2559 | 12.09 |
12:02 ET | 2921 | 12.12 |
12:03 ET | 2108 | 12.1172 |
12:05 ET | 4829 | 12.075 |
12:07 ET | 4860 | 12.0339 |
12:09 ET | 5745 | 12.01 |
12:12 ET | 11062 | 12.015 |
12:14 ET | 1657 | 12.025 |
12:16 ET | 6173 | 12.11 |
12:18 ET | 2620 | 12.07 |
12:20 ET | 500 | 12.04 |
12:23 ET | 1420 | 12.01 |
12:25 ET | 10600 | 12.045 |
12:27 ET | 854 | 12.09 |
12:30 ET | 682 | 12.07 |
12:32 ET | 600 | 12.1 |
12:34 ET | 3478 | 12.125 |
12:36 ET | 268 | 12.1156 |
12:38 ET | 1185 | 12.11 |
12:39 ET | 3107 | 12.14 |
12:41 ET | 4529 | 12.13 |
12:43 ET | 1854 | 12.12 |
12:48 ET | 2356 | 12.07 |
12:50 ET | 646 | 12.105 |
12:54 ET | 1686 | 12.06 |
12:56 ET | 256 | 12.065 |
12:57 ET | 1727 | 12.07 |
12:59 ET | 2996 | 12.08 |
01:01 ET | 3600 | 12.1 |
01:03 ET | 1211 | 12.07 |
01:08 ET | 1545 | 12.08 |
01:10 ET | 512 | 12.03 |
01:12 ET | 3475 | 12.05 |
01:14 ET | 1760 | 12.06 |
01:15 ET | 1235 | 12.02 |
01:17 ET | 100 | 12.02 |
01:19 ET | 100 | 12.02 |
01:21 ET | 1000 | 12.015 |
01:24 ET | 5833 | 12.04 |
01:26 ET | 1433 | 12.08 |
01:28 ET | 400 | 12.07 |
01:30 ET | 629 | 12.06 |
01:32 ET | 447 | 12.08 |
01:33 ET | 500 | 12.06 |
01:35 ET | 800 | 12.06 |
01:37 ET | 100 | 12.05 |
01:39 ET | 807 | 12.05 |
01:42 ET | 2039 | 12.03 |
01:44 ET | 1200 | 12.02 |
01:46 ET | 519 | 12.02 |
01:48 ET | 1604 | 12.03 |
01:50 ET | 1083 | 12.02 |
01:51 ET | 23669 | 12.09 |
01:53 ET | 7814 | 12.0675 |
01:55 ET | 1287 | 12.05 |
01:57 ET | 768 | 12.06 |
02:00 ET | 900 | 12.03 |
02:02 ET | 300 | 12.02 |
02:04 ET | 847 | 12.02 |
02:06 ET | 5501 | 12.02 |
02:08 ET | 801 | 12.025 |
02:09 ET | 5912 | 12.03 |
02:11 ET | 553 | 12.03 |
02:13 ET | 429 | 12.035 |
02:15 ET | 834 | 12.035 |
02:18 ET | 43309 | 11.955 |
02:20 ET | 18379 | 12.03 |
02:22 ET | 35800 | 12.015 |
02:24 ET | 1057 | 12.04 |
02:26 ET | 4104 | 12.025 |
02:27 ET | 3934 | 12.07 |
02:29 ET | 1800 | 12.05 |
02:31 ET | 654 | 12.035 |
02:33 ET | 1942 | 12.03 |
02:36 ET | 900 | 12.03 |
02:38 ET | 1000 | 12.02 |
02:40 ET | 4005 | 12.04 |
02:42 ET | 950 | 12.05 |
02:44 ET | 1782 | 12.03 |
02:45 ET | 1085 | 12.025 |
02:47 ET | 3305 | 12 |
02:49 ET | 8745 | 12 |
02:51 ET | 6679 | 12.06 |
02:54 ET | 725 | 12.04 |
02:56 ET | 7156 | 12.02 |
02:58 ET | 3092 | 12.04 |
03:00 ET | 765 | 12.02 |
03:02 ET | 1670 | 12 |
03:03 ET | 1346 | 11.99 |
03:05 ET | 2118 | 12 |
03:07 ET | 2987 | 12.005 |
03:09 ET | 2601 | 12.03 |
03:12 ET | 2364 | 12.02 |
03:14 ET | 6368 | 12.01 |
03:16 ET | 3513 | 12.0101 |
03:18 ET | 801 | 12.02 |
03:20 ET | 8067 | 12.04 |
03:21 ET | 3407 | 11.975 |
03:23 ET | 644 | 11.985 |
03:25 ET | 2189 | 11.98 |
03:27 ET | 1406 | 11.98 |
03:30 ET | 6389 | 11.985 |
03:32 ET | 27533 | 12 |
03:34 ET | 1097 | 12.005 |
03:36 ET | 5039 | 12.02 |
03:38 ET | 3745 | 12.02 |
03:39 ET | 4492 | 12.03 |
03:41 ET | 22658 | 12.06 |
03:43 ET | 15169 | 12.02 |
03:45 ET | 5571 | 12.03 |
03:48 ET | 12636 | 11.98 |
03:50 ET | 9734 | 12.03 |
03:52 ET | 13593 | 12.025 |
03:54 ET | 27325 | 12.02 |
03:56 ET | 19640 | 11.98 |
03:57 ET | 23506 | 11.96 |
03:59 ET | 69144 | 11.98 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.4B | -3.0x | --- |
Arcus Biosciences Inc | 1.4B | -5.1x | --- |
Immatics NV | 1.1B | -12.8x | --- |
Prothena Corporation PLC | 1.1B | -6.7x | --- |
Protagonist Therapeutics Inc | 1.7B | 13.8x | --- |
Silence Therapeutics PLC | 979.4M | -19.4x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | 17.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.